We have examined and compared at the molecular level three strains of wild-type yellow fever (YF) virus isolated from Senegal in 1927, 1953 and 1965, termed French viscerotropic virus, Rendu and Dak1279 respectively. Over the structural protein genes, Rendu differed from the other two strains by 8 % at the nucleotide level. Rendu also differed antigenically, possessing a ' vaccine '-specific envelope (E) protein epitope (i.e. an epitope previously shown to be found on 17D and French neurotropic vaccine viruses only and not wild-type strains of YF virus). Consequently, we propose that at least two distinct genotypes of wild-type YF virus have been present in Senegal. Since Rendu virus was isolated from a fatal case of YF, it would indicate that the vaccine-specific epitope on the E protein is not associated with attenuation of the viscerotropism of wild-type YF virus.
The genus Flavivirus of the family Flaviviridae contains some 70 enveloped, single-stranded, positive-sense RNA viruses, including yellow fever (YF) virus. Wild-type YF virus strains have been relatively poorly studied in recent years (Clarke, 1960 ; Deubel et al., 1985 Gould et al., 1985 ; Lepiniec et al., 1994 ; Chang et al., 1995) . The entire nucleotide and deduced amino acid sequence is available for only two strains of wild-type YF virus, the West African strains Asibi (Hahn et al., 1987) , which was isolated in Ghana in 1927, and French viscerotropic virus (FVV) (Wang et al., 1995 Ballinger-Crabtree & Miller, 1990) , the envelope (E) protein genes of 17 strains (Chang et al., 1995) , and deduced from the 116 amino acids of the E protein from 22 wild-type strains isolated from different geographical regions of Africa (Lepiniec et al., 1994) . This paper compares three wild-type YF viruses isolated from Senegal over a period of 38 years (strains FVV, Rendu and Dak1279). Their nucleotide and amino acid sequence homology was studied over one-third of the genome (encoding the structural proteins and a non-structural protein, NS2A). We demonstrate that Rendu is different from all other West African wild-type YF viruses analysed to date, whereas FVV and Dak1279 are very closely related at the genetic level to each other and to previously studied YF viruses (Lepiniec et al., 1994 ; Chang et al., 1995) . Table 1 shows the origins of the viruses used in this study. FVV, Rendu and Dak1279 viruses were all isolated from humans in Senegal in 1927 Senegal in , 1953 Senegal in and 1965 Fitzgeorge & Bradish (1980) and Gould et al. (1985) refer to this virus as Y5]. The viruses were passaged once, in either SW13 or Vero cells, to provide working stocks and for extraction of viral RNA for molecular analysis. RT-PCR, cloning and sequencing were performed as described previously . Both strands of two or more clones were sequenced for each PCR product.
We have previously described the derivation of four ' wildtype '-specific and one ' vaccine '-specific E protein-reactive MAbs (Sil et al., 1992) . The wild-type-specific MAbs S17, S18, S24 and S56 reacted with the five wild-type viruses in indirect immunofluoresence tests. However, the vaccine-specific MAb H5, which had previously been shown to recognize only 17D-204, 17DD and French neurotropic vaccine (FNV) viruses, also reacted with wild-type virus Rendu ( Rendu with MAb H5 was confirmed in haemagglutination inhibition assays (data not shown). Table 2 summarizes amino acid and nucleotide differences identified between the structural proteins and their genes in Asibi (previously published by Hahn et al., 1987) , FVV (Wang et al., 1995) and B4.1 (Ballinger-Crabtree & Miller, 1990) viruses and the two Senegalese viruses examined in this paper (Rendu and Dak1279). At the nucleotide level, Rendu was shown to differ relatively greatly (8 %) over the region encoding the structural proteins from the other three West African wild-type YF viruses (Asibi, FVV and Dak1279). At many nucleotide positions, B4.1 and Rendu shared the same nucleotide which was different from that in the other three West African viruses. These nucleotides almost always proved to be at the third position in codons (data not shown). All four West African viruses were identical over the 5' non-coding region.
Despite the large nucleotide variation, there were relatively few amino acid differences observed between the four West African wild-type viruses (0n4-1n2 %) over the structural proteins (Tables 2 and 3 ). All the substitutions unique to Rendu virus were found in the E protein (Table 3) . However, the four West African viruses differed to a larger extent from the South American virus B4.1.
Although 38 years separate the isolation of FVV from that 
of Dak1279, these two viruses were found to be very similar at the amino acid level over the structural proteins, with only eight amino acid differences [one in each core (C), precursor membrane (prM) and membrane (M) protein, and five in the E protein] between them. The change at amino acid 119 observed in both Rendu and Dak1279 viruses (where an alanine replaces the threonine found in other strains) occurs within the C\prM cleavage site (Chambers et al., 1990) . The consensus cleavage sequence for YF viruses, based on the results presented in this and other publications (Jennings et al., 1993 b ; Hahn et al., 1987 ; Rice et al., 1985 ; Ballinger-Crabtree & Miller, 1990) , is LLMTGG VTLVRK. The enzyme which effects cleavage at this site is thought to be a host-specified signalase (Chambers et al., 1990) . However, in Rendu and Dak1279 viruses, the threonine preceding the cleavage point is replaced with an alanine to produce the sequence LLMAGG VTLVRK. This is the first cleavage site which has been shown to differ between YF virus strains.
Although a relatively higher rate of amino acid substitution was observed in the E protein between Rendu and the other BDFA three wild-type African viruses, nucleotide changes were randomly distributed in the region examined. These results suggest that the E protein may be subject to greater selection pressure than M, prM or NS2A proteins (see below). This is not surprising since the E protein is the major antigenic and immunogenic protein in flaviviruses. When the West African viruses were compared with the South American wild-type B4.1, the difference was even greater, with 214-239 nucleotide differences in the E protein gene (14-16 %). The number of amino acid differences ranges from 15 (B4.1 vs Dak1279) to 20 (B4.1 vs Rendu), giving a divergence of 3-4 % at the amino acid level.
Rendu virus had unique amino acid residues at E protein positions E-124, E-405 and E-430, and variation was also seen at positions E-407 and E-416 (Table 3) . At position E-407, Asibi, Dak1279, B4.1 and FNV viruses have an alanine residue while FVV and the 17D vaccine viruses have a conservative substitution to a valine. However, in Rendu a non-conservative change to glutamine was seen, altering the hydrophilicity of the E protein in this region. At position E-416 in YF virus (or the equivalent position in other flaviviruses), a threonine residue is conserved in all mosquitoborne flaviviruses so far sequenced (Marin et al., 1995) , including Rendu and the 17D-204 vaccine strain. However, in FNV, Asibi, FVV and B4.1 viruses an alanine is found in this position, whilst in 17DD viruses a valine is seen. This is a high degree of variation at a position which does not appear to vary among other mosquito-borne flaviviruses.
To determine if the pattern of high nucleotide but relatively low amino acid divergence was limited to the structural protein genes, NS2A was also analysed and the results for this nonstructural protein paralleled those seen in the structural proteins (data not shown).
Although Dak1279 was isolated 12 years after Rendu, it is much more similar to Asibi and FVV. This would suggest that, although these viruses were isolated from Senegal, Rendu belongs to a different topotype or genotype of wild-type YF viruses from Asibi, FVV and Dak1279, or the Senegalese isolates examined by Lepiniec et al. (1994) . Examination of the epidemiology of YF virus in Senegal [reviewed by Monath (1989) ] supports the molecular data described in this paper. A succession of YF epidemics took place in Senegal until the derivation and administration of FNV in the 1930s. This resulted in only five cases of YF being reported in Senegal between 1940 and 1964, including the one from which Rendu was isolated. Following reduced vaccination, however, another YF epidemic took place in 1965, from which Dak1279 was isolated. It is possible to speculate that, while FVV and Dak1279 are viruses endemic to Senegal and controlled by the vaccination programme, Rendu was introduced from outside Senegal. This would explain the extensive homology of viruses isolated before 1940 and after 1965.
Comparison of the E protein sequence of Rendu with sequences reported by Chang et al. (1995) revealed that Rendu is a member of the West African genotype described by Chang et al. The Dak1279 sequence reported by Chang et al. differed from that reported in this study by two residues and E-416 (threonine in this study)]. Thus, E-416 is not unique in Rendu virus. Similarly, the isoleucine at E-430 in Rendu virus was also seen in two Nigerian strains. Therefore, Rendu differed from all other YF virus strains sequenced to date at E-124, E-405 and E-407. Lepiniec et al. (1994) reported the nucleotide sequence of 348 nucleotides in the E protein gene of 18 wild-type strains of YF virus from different parts of Africa. Rendu virus differs from the reference strain Asibi at 26 nucleotide positions, of which 6 are unique to strain Rendu. Of the strains examined by Lepiniec et al. (1994) , the human isolate AMT\7 from the Ivory Coast in 1973 was most closely related to Rendu, with AMT\7 and Rendu viruses sharing 17 nucleotide differences from Asibi. However, at the amino acid level, Rendu was unique among all the other strains studied, including AMT\7, at position E-405. Although further studies are required to determine any relationship between Rendu and strains from Nigeria and the Ivory Coast, comparison with the strains studied by Chang et al. (1995) indicated that the Rendu strain was unique.
The most striking point to emerge is that there appears to have been little variation in the structural proteins of wild-type YF virus in Ghana and Senegal over 38 years, as evidenced by the nucleotide sequence similarity of FVV and Asibi to Dak1279 described here, the sequence studies of Lepiniec et al. (1994) and Chang et al. (1995) , and the T1 mapping studies of Deubel et al. (1985) . The differences between Rendu and the other Senegalese isolates at both the nucleotide and the amino acid levels suggest that this virus should not be grouped with the other Senegalese viruses analysed to date, and in fact may represent a different genotype of African wild-type YF virus not normally found in Senegal.
Finally, Gould et al. (1985) reported that Rendu virus possessed an E protein epitope, recognized by MAb 411, that was found to be specific to vaccine\attenuated strains of YF virus (Barrett et al., 1990 ) and which was not found on 22 other African and South American wild-type YF strains. Similarly, we have found that Rendu virus has the E protein vaccine-specific epitope recognized by MAb H5. Nine other wild-type YF isolates from South America, East Africa and West Africa which were tested did not have the MAb H5 vaccine epitope (data not shown). Thus, on the basis of the wild-type strains analysed to date, Rendu is unique in presenting both wildtype-and vaccine-specific epitopes on its E protein. Since Rendu was isolated from a fatal case of YF and does not appear to be a naturally attenuated YF virus, it is suggested that the presence of a vaccine-specific epitope on the E protein is not associated with attenuation of the viscerotropism of wild-type YF virus.
As there was no common amino acid substitution found in the E protein of Rendu and vaccine viruses from other wildtype YF viruses, it seems likely that the vaccine epitope is BDFB
